发明名称 |
Formulations of organic compounds |
摘要 |
The present invention relates to solid pharmaceutical compositions comprising the phosphatidylinositol 3-kinase inhibitor compound 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine or a pharmaceutically acceptable salt thereof, sodium stearyl fumarate, and optionally at least one additional pharmaceutically acceptable carrier. The present invention also relates to the processes for their preparation and to their use as medicaments for the treatment of cancer. |
申请公布号 |
AU2014224238(A1) |
申请公布日期 |
2015.09.03 |
申请号 |
AU20140224238 |
申请日期 |
2014.03.04 |
申请人 |
NOVARTIS AG |
发明人 |
KOCHHAR, CHARU;QUINTON, JACQUES |
分类号 |
A61K9/16;A61K9/20;A61K31/5377;A61K35/00;A61K47/14 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|